[1]CurrentPatentAssignee:CRISTALIAPRODUTOSQUIMICOSFARMACEUTICOS,LTDA-EP2905278,2015,A1Locationinpatent:Paragraph0158
[1]Griffiths,RobertJ.;Burley,GlennA.;Talbot,EricP.A.[OrganicLetters,2017,vol.19,#4,p.870-873]
Title: Development of orally disintegrating tablets comprising controlled-release multiparticulate beads.
Journal: Drug development and industrial pharmacy 20121101
Title: Melperone is ineffective in treating Parkinson's disease psychosis.
Journal: Movement disorders : official journal of the Movement Disorder Society 20120501
Title: Auditing clinical outcomes after introducing off-licence prescribing of atypical antipsychotic melperone for patients with treatment refractory schizophrenia.
Journal: TheScientificWorldJournal 20120101
Title: Changes in weight and body mass index during treatment with melperone, clozapine and typical neuroleptics.
Journal: Psychiatry research 20100430
Title: Melperone, an aytpical antipsychotic drug with clozapine-like effect on plasma prolactin: contrast with typical neuroleptics.
Journal: Human psychopharmacology 20090701
Title: Diminished glucocorticoid negative feedback in polydipsic hyponatremic schizophrenic patients.
Journal: The Journal of clinical endocrinology and metabolism 20070201
Title: Cytochrome P450 2D6 dependent metabolization of risperidone is inhibited by melperone.
Journal: European journal of clinical pharmacology 20060401
Title: Atypical and typical antipsychotic drug interactions with the dopamine D2 receptor.
Journal: European journal of medicinal chemistry 20050201
Title: P-glycoprotein is a factor in the uptake of dextromethorphan, but not of melperone, into the mouse brain: evidence for an overlap in substrate specificity between P-gp and CYP2D6.
Journal: Journal of psychopharmacology (Oxford, England) 20041201
Title: Discriminative stimulus properties of 1.25 and 5.0 mg/kg doses of clozapine in rats: examination of the role of dopamine, serotonin, and muscarinic receptor mechanisms.
Journal: Pharmacology, biochemistry, and behavior 20040201
Title: [Treatment of behavioral disorders in dementia with risperidone in psychogeriatric out-patients].
Journal: MMW Fortschritte der Medizin 20031009
Title: A comparison of two doses of melperone, an atypical antipsychotic drug, in the treatment of schizophrenia.
Journal: Schizophrenia research 20030701
Title: The effect of melperone, an atypical antipsychotic drug, on cognitive function in schizophrenia.
Journal: Schizophrenia research 20030101
Title: Melperone is an inhibitor of the CYP2D6 catalyzed O-demethylation of venlafaxine.
Journal: Pharmacopsychiatry 20030101
Title: Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism.
Journal: Brain research 20021129
Title: [Atypical neuroleptics in dementia. Managing behavioral disorders early and efficiently].
Journal: MMW Fortschritte der Medizin 20020307
Title: Melperone in the treatment of neuroleptic-resistant schizophrenia.
Journal: Psychiatry research 20011231
Title: [Practical experiences in the therapy of postweaning edema disease in piglets].
Journal: Berliner und Munchener tierarztliche Wochenschrift 19961001
Title: Dopamine D4 versus D2 receptor selectivity of dopamine receptor antagonists: possible therapeutic implications.
Journal: European journal of pharmacology 19930604
